JP7306661B2 - 消化管間質腫瘍を検出する方法および検出試薬 - Google Patents

消化管間質腫瘍を検出する方法および検出試薬 Download PDF

Info

Publication number
JP7306661B2
JP7306661B2 JP2022508218A JP2022508218A JP7306661B2 JP 7306661 B2 JP7306661 B2 JP 7306661B2 JP 2022508218 A JP2022508218 A JP 2022508218A JP 2022508218 A JP2022508218 A JP 2022508218A JP 7306661 B2 JP7306661 B2 JP 7306661B2
Authority
JP
Japan
Prior art keywords
azu1
antibody
gist
reagent
manufactured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022508218A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021187173A1 (fr
Inventor
幸嗣 植田
なおみ 大西
久裕 松原
将之 加野
則久 大竹
康俊 河合
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Chiba University NUC
Tosoh Corp
Original Assignee
Japanese Foundation for Cancer Research
Chiba University NUC
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Chiba University NUC, Tosoh Corp filed Critical Japanese Foundation for Cancer Research
Publication of JPWO2021187173A1 publication Critical patent/JPWO2021187173A1/ja
Application granted granted Critical
Publication of JP7306661B2 publication Critical patent/JP7306661B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
JP2022508218A 2020-03-19 2021-03-05 消化管間質腫瘍を検出する方法および検出試薬 Active JP7306661B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020048601 2020-03-19
JP2020048601 2020-03-19
PCT/JP2021/008777 WO2021187173A1 (fr) 2020-03-19 2021-03-05 Méthode de détection de tumeur stromale gastro-intestinale et réactif de détection

Publications (2)

Publication Number Publication Date
JPWO2021187173A1 JPWO2021187173A1 (fr) 2021-09-23
JP7306661B2 true JP7306661B2 (ja) 2023-07-11

Family

ID=77771828

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022508218A Active JP7306661B2 (ja) 2020-03-19 2021-03-05 消化管間質腫瘍を検出する方法および検出試薬

Country Status (2)

Country Link
JP (1) JP7306661B2 (fr)
WO (1) WO2021187173A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012088220A (ja) 2010-10-21 2012-05-10 Shinya Watanabe Ｇｉｓｔ検出用マーカー
JP2012088221A (ja) 2010-10-21 2012-05-10 Shinya Watanabe Ｇｉｓｔの診断方法
JP2013128434A (ja) 2011-12-20 2013-07-04 Sapporo Medical Univ 消化管間質腫瘍マーカー
US20170153240A1 (en) 2015-11-30 2017-06-01 Sungkwang Medical Foundation Composition, kit, and method for diagnosing and treating ovarian cancer
WO2018079689A1 (fr) 2016-10-28 2018-05-03 公益財団法人がん研究会 Biomarqueur, procédé de recherche d'un gène associé à une maladie, et marqueur du cancer du rein
WO2018217087A1 (fr) 2017-05-23 2018-11-29 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Nouveaux biomarqueurs protéiques basés sur les selles pour le dépistage du cancer colorectal

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012088220A (ja) 2010-10-21 2012-05-10 Shinya Watanabe Ｇｉｓｔ検出用マーカー
JP2012088221A (ja) 2010-10-21 2012-05-10 Shinya Watanabe Ｇｉｓｔの診断方法
JP2013128434A (ja) 2011-12-20 2013-07-04 Sapporo Medical Univ 消化管間質腫瘍マーカー
US20170153240A1 (en) 2015-11-30 2017-06-01 Sungkwang Medical Foundation Composition, kit, and method for diagnosing and treating ovarian cancer
WO2018079689A1 (fr) 2016-10-28 2018-05-03 公益財団法人がん研究会 Biomarqueur, procédé de recherche d'un gène associé à une maladie, et marqueur du cancer du rein
WO2018217087A1 (fr) 2017-05-23 2018-11-29 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Nouveaux biomarqueurs protéiques basés sur les selles pour le dépistage du cancer colorectal

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
植田幸嗣，切除組織培養分泌エクソソームの網羅的解析によるがん早期診断薬開発，医学のあゆみ，2019年11月30日，Vol.271, No.9，PP.829-835

Also Published As

Publication number Publication date
JPWO2021187173A1 (fr) 2021-09-23
WO2021187173A1 (fr) 2021-09-23

Similar Documents

Publication Publication Date Title
US9244079B2 (en) Testing method and testing reagent for angiitis
US20120271124A1 (en) Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
US11892457B2 (en) Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis
WO2013035799A1 (fr) Anticorps apte à se lier à une région spécifique de la périostine, et procédé de mesure de la périostine à l'aide de celui-ci
EP2673646B1 (fr) Méthode de diagnostic d'une infection des voies urinaires
CN109069600A (zh) Il-21抗体及其用途
US20170097352A1 (en) Immunoglobulin-bound extracellular vesicles and uses thereof
US11965887B2 (en) Method of examining possibility of subject having pancreatic cancer
JP7127422B2 (ja) 癌を検出する方法及び検出試薬
JP7449530B2 (ja) 腎癌の検出方法及び検査薬
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法
EP3537152B1 (fr) Méthode d'immunoessai permettant de déterminer une concentration de rénine
JP7306661B2 (ja) 消化管間質腫瘍を検出する方法および検出試薬
JP7546255B2 (ja) 癌を検出する方法および検出試薬
JP6760562B2 (ja) 卵巣明細胞癌患者の予後を予測するための情報提供方法
EP4063845A1 (fr) Procédé de détection de métastase osseuse de cancer et réactif de détection
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
WO2021246153A1 (fr) Méthode et réactif de détection de cancers pancréatiques

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230508

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230621

R150 Certificate of patent or registration of utility model

Ref document number: 7306661

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150